Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIVID: Inhaled Therapies for Acute COVID-19 Symptoms
NCT04937543Phase 2Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Botucatu
- Start
- Jun 2021
- Primary completion
- Oct 2021
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium in coronavirus disease 2019 (COVID-19), sponsored by Hospital das Clínicas da Faculdade de Medicina de Botucatu. Started Jun 2021; status: completed.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrronium
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04937543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04937543.